Clinical Trials
16 trialsNCT04037254 2026-05-20
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
NRG Oncology
Phase 1/2 Completed
NCT01420250 2025-05-15
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer
Thomas Jefferson University
Phase 1 Completed
NCT01985828 2024-10-03
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
Wake Forest University Health Sciences
Phase NA Completed
NCT00482807 2023-11-24
Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer
University of Nebraska
Phase 1 Completed
NCT01666808 2023-08-02
FACBC Outcomes for Post Prostatectomy
Emory University
Phase 2/3 Completed
NCT00033631 2023-01-18
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00331773 2023-01-18
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT02064036 2022-10-18
CCRO025
University of California, Davis
Phase 1 Completed
NCT00288080 2022-06-21
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT01325961 2021-05-24
RCMI PELVIS
Institut Cancerologie de l'Ouest
Phase NA Completed
NCT00714753 2019-08-07
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer
Mayo Clinic
Phase 2 Completed
NCT01028885 2019-07-25
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00551525 2017-07-25
Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer
Radiation Therapy Oncology Group
Phase 2 Completed
NCT02974231 2016-11-28
Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer
Institut de Cancérologie de Lorraine
Completed
NCT00349557 2014-07-16
Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer
Benaroya Research Institute
Phase 2 Completed
NCT00653757 2012-03-19
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer
Mayo Clinic
Phase 1/2 Completed